Sensitivity to change of composite and frequency scores of the Neuropsychiatric Inventory in mild to moderate dementia

International Psychogeriatrics

Volumn 25, Issue 3, 2013, Pages 431-438

  Cummings, Jeffrey L ^a   Ihl, Ralf ^b   Herrschaft, Horst ^c   Hoerr, Robert ^d   Tribanek, Michael ^e  

^a LERNER RESEARCH INSTITUTE   (United States)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c UNIVERSITY OF COLOGNE   (Germany)

^d DR WILLMAR SCHWABE GMBH AND CO KG   (Germany)

^e Statistician   (Germany)

Author keywords

assessment; behavior; NPI; psychometric properties

Indexed keywords

GINKGO BILOBA EXTRACT; PLACEBO;

ADULT; AGED; ARTICLE; CALCULATION; COGNITION; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL PERFORMANCE; MENTAL TEST; NEUROPSYCHIATRIC INVENTORY; NEUROPSYCHOLOGICAL TEST; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL (TOPIC); SCORING SYSTEM; SENILE DEMENTIA; SENSITIVITY ANALYSIS; STANDARDIZATION; TREATMENT RESPONSE;

AGED; DEMENTIA; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PHYTOTHERAPY; PLANT EXTRACTS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOPATHOLOGY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REGRESSION ANALYSIS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 84873815714     PISSN: 10416102     EISSN: 1741203X     Source Type: Journal    
DOI: 10.1017/S1041610212001974     Document Type: Article

References (21)

1. Alzheimer, A. (1907). Über eine eigenartige Erkrankung der Hirnrinde. Allgemeine Zeitschrift für Psychiatrie und Psychisch- Gerichtliche Medizin (Berlin), 64, 146-148.
2. American Psychiatric Association (2000). Diagnostic and Statistical Manual of Mental Disorders, 4th edn, text revision (DSM-IV-TR R -) . Washington, DC: American Psychiatric Association.
3. Chan, D. C., Kasper, J. D., Black, B. S. and Rabins, P. V. (2003). Prevalence and correlates of behavioral and psychiatric symptoms in community-dwelling elders with dementia or mild cognitive impairment: The Memory and Medical Care Study. International Journal of Geriatric Psychiatry, 18, 174-182.
4. Cummings, J. L. (1997). The Neuropsychiatric Inventory: Assessing psychopathology in dementia patients. Neurology, 48, S10-S16.
5. Cummings, J. L., Mega, M., Gray, K., Rosenberg-Thompson, S., Carusi, D. A. and Gornbein, J. (1994). The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology, 44, 2308-2314.
6. de Medeiros, K. et al. (2010). The Neuropsychiatric Inventory-Clinician rating scale (NPI-C): reliability and validity of a revised assessment of neuropsychiatric symptoms in dementia. International Psychogeriatrics, 22, 984-994. doi:10.1017/S1041610210000876.
7. Dubois, B. et al. (2007). Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurology, 6, 734-746.
8. Dubois, B. et al. (2010). Revising the definition of Alzheimer's disease: A new lexicon. Lancet Neurology, 9, 1118-1127.
9. Gauthier, S. et al. (2010). Management of behavioral problems in Alzheimer's disease. International Psychogeriatrics, 22, 346-372.
10. Geda, Y. E. et al. (2008). Prevalence of neuropsychiatric symptoms in mild cognitive impairment and normal cognitive aging. Archives of General Psychiatry, 65, 1193-1198.
11. Herrschaft, H., Nacu, A., Likhachev, S., Sholomov, I., Hoerr, R., Schlaefke, S., on behalf of the GOT-IT! Study Group (2012). Ginkgo biloba extract EGb 761 R - in dementia with neuropsychiatric features: A randomized, placebo-controlled trial to confirm the efficacy and safety of a daily dose of 240 mg. Journal of Psychiatric Research, 46, 716-723.
12. Ihl, R., Grass-Kapanke, B., Jänner, M. and Weyer, G. (1999). Neuropsychometric tests in cross sectional and longitudinal studies Y a regression analysis of ADASCog, SKT and MMSE. Pharmacopsychiatry, 32, 248-254.
13. Ihl, R. et al. (2011). Efficacy and safety of a once-daily formulation of Ginkgo biloba extract EGb 761 R - in dementia with neuropsychiatric features: A randomized controlled trial. International Journal of Geriatric Psychiatry, 26, 1186-1194. doi:10.1002/gps.2662.
14. Lyketsos, C. G. (2007). Neuropsychiatric symptoms (behavioral and psychological symptoms of dementia) and the development of dementia treatments. International Psychogeriatrics, 19, 409-420. doi:10.1017/S104161020700484X.
15. Lyketsos, C. G., Steinberg,M., Tschanz, J. T., Norton, M. C., Steffens, D. C. and Breitner, J. C. S. (2000). Mental and behavioral disturbances in dementia: findings from the Cache County Study on Memory in Aging. American Journal of Psychiatry, 157, 708-714.
16. Lyketsos, C. G., Lopez, O., Jones, B., Fitzpatrick, A. L., Breitner, J. and DeKosky, S. (2002). Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment. Results from the Cardiovascular Health Study. JAMA, 288, 1475-1483.
17. McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D. and Stadlan, E. M. (1984). Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology, 34, 939-944.
18. Napryeyenko, O., Borzenko, I., for the GINDEM-NP Study Group (2007). Ginkgo biloba special extract in dementia with neuropsychiatric features. A randomized, placebo-controlled, double-blind clinical trial. Arzneimittelforschung, 57, 4-11.
19. Román, G. C. et al. (1993). Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology, 43, 250-260.
20. Steinberg, M. et al. (2008). Point and 5-year period prevalence of neuropsychiatric symptoms in dementia: The Cache County Study. International Journal of Geriatric Psychiatry, 23, 170-177.
21. Stelzmann, R. A., Schnitzlein, H. N. and Murtagh, F. R. (1995). An English translation of Alzheimer's 1907 paper, "Über eine eigenartige Erkrankung der Hirnrinde. Clinical Anatomy, 8, 429-431.